The Valley Desk

Clinical trial reportThe Journal of clinical investigationPublished

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Clinical trial report
Venue
The Journal of clinical investigation
Published
Subject terms
Humans; Muscular Atrophy, Spinal; Spinal Muscular Atrophies of Childhood; Recombinant Fusion Proteins; Oligonucleotides; Biological Products; Child, Preschool; Infant; Female; Male; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein
PubMed ID
40956616
PubMed Central ID
PMC12618081
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal